FY23 Corporate Strategy and Sustainability Journey
Core businesses - Branded Markets
India - 2X growth in last four years
Driving strong outcome
16
Brands in IPM
Top 300
Brands with
>100Cr+
15+
12
MQT Rank in the
IPM
• Aim to be among Top-5 in India
• Focus areas
Horizon-1 - Build big brands, winning in chosen therapy/ disease areas (through
differentiated portfolio & inorganic play) & S&M productivity (using digi-analytics)
Horizon-2- Nutraceuticals, OTC, biologics, CAR-T, NCE / NBE, condition &
disease management, digital ecosystem play & others
Emerging Markets - 2X growth in last five years
Driving strong outcome
•
Markets added
13
in last 5 years
Russia - 40 products, 6 mega-brands, & 800+ employees
China - Double-digit filings annually
Serving patients
48
in 48 countries
11
520
Filings in last 4
years
Brands with
>100 Cr+
• Focus areas
Horizon-1 - Grow Mega-brands (Rx & OTC), Leverage global portfolio in EM &
S&M excellence
Horizon-2 - Differentiated formulations, Nutrition portfolio, Biologics, NCE / NBE,
Disease management & Direct-to-Customer
18
Source: Internal analysis, IQVIA *Pipeline means products filed or in under development stage or approved but yet to be launched
©copyright Dr. Reddy's Ltd.View entire presentation